We found that depletion of CLIC1 with shRNA in A549 human lung cancer cells increased DNA double-strand breaks both under control conditions and under treatment with the putative anticancer agent chelerythrine, with a concomitant increase in p-JNK levels. The gene discussed is CLIC1; the disease is lung carcinoma.